资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies

Cancer Cell. 2022-05;

Robert Stuver, Gunjan L Shah, Neha S Korde, Lindsey E Roeker, Anthony R Mato, Connie L Batlevi, David J Chung, Sital Doddi, Lorenzo Falchi, Boglarka Gyurkocza, Audrey Hamilton, Ya-Hui Lin, Ann A Jakubowski, Erel Joffe, Heather L Landau, Richard J Lin, Sham Mailankody, M Lia Palomba, Jae H Park, Miguel-Angel Perales, Doris M Ponce, Lakshmi V Ramanathan, Gilles A Salles, Michael Scordo, Susan K Seo, Urvi A Shah, Eytan M Stein, David Straus, Saad Z Usmani, James W Young, Andrew D Zelenetz, Ariela Noy, Santosha A Vardhana

Products/Services Used	Details	Operation
Recombinant Proteins	… Virus neutralization was measured using the SARSCoV-2 surrogate virus neutralization test kit (Genscript), and percent inhibition was calculated per manufacturer’s instructions with a …	Get A Quote